- Education, Training & Outreach
- Patients & Caregivers
- For Investigators
- Dementia in the News
- Media Room
A Phase II, Multi-Center, Double-Blind Study of BMS-708163 in the Treatment of Patients with Prodromal Alzheimer's Disease
We are now enrolling men and women, ages 45 to 90, with memory loss or mild cognitive impairment (MCI) to participate in this study. A study partner will also be needed to participate in this study. Volunteers may receive investigational medication, study-related medical care, laboratory testing and cognitive testing.
Martha Vander Vliet, RN